Study of unexplained bleeding blood tests in adults
Part of Blood & lymphatic, Heart & circulation clinical trials.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (man or woman) with a higher-than-usual bleeding score from the study’s checklist
- If your score includes surgical bleeding (men) or surgical/postpartum bleeding (women), at least two other score items must also be above zero
- You cannot be currently pregnant
- You must not have taken blood-thinning medicines or NSAID pain relievers for at least 10 days before the blood draw
- You must not have taken antifibrinolytic medicine or had blood products/factor concentrates for at least 14 days before the blood draw
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This study follows people with inherited or acquired non-cancer blood disorders to better understand symptoms, causes, and how different treatments work over time. You may be placed into a disorder-specific group, depending on your diagnosis and testing results.
This trial uses early genetic testing to find the cause of unexplained bleeding in people who may have an inherited bleeding disorder. The goal is to see if genetic testing can help diagnose these conditions sooner.
This study is for people who have a history of unusual bleeding but whose standard blood tests have not found a known bleeding disorder. Researchers hope to learn more about what causes these unexplained bleeding problems.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
This study uses a special blood test to create a score that predicts bleeding risk in patients with blood cancers and very low platelet counts. It could help doctors decide if you need extra care to prevent bleeding.
Hear when a new Bleeding Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.